| Antimicrobial agents |
Susceptibility patterns |
% response behaviour of isolates |
| E. coli |
OXA Variants |
P. aeruginosa |
OXA Variants |
| Cefepime |
S |
24.5 |
OXA-1. OXA-2,OXA-10 |
17.6 |
OXA-1. OXA-2 |
| I |
12.2 |
OXA-10 |
27 |
OXA-10 |
| R |
63.3 |
OXA-23,OXA-24, OXA-48, OXA-51, OXA-58 |
55.4 |
OXA-23,OXA-24, OXA-48, OXA-51, OXA-58 |
| Cefepime plus sulbactam |
S |
87.8 |
OXA-1. OXA-2, OXA-10, OXA-23, OXA-24, OXA-48, OXA-51 |
86.5 |
OXA-1, OXA-2, OXA-10, OXA-23, OXA-24, OXA-48, OXA-51 |
| I |
8.2 |
OXA-48, OXA-51, OXA-58 |
5.4 |
OXA-48, |
| R |
4.1 |
OXA-58 |
8.1 |
OXA-51,OXA-58, |
| Cefepime plus tazobactam |
S |
73.5 |
OXA-1. OXA-2, OXA-10, OXA-23, OXA-24, OXA-48, OXA-51 |
72.2 |
OXA-1. OXA-2, OXA-10, OXA-23, OXA-24, OXA-48 |
| I |
8.2 |
OXA-48 |
14.9 |
OXA-48, OXA-51, OXA-58 |
| R |
18.4 |
OXA-51, OXA-58 |
14.9 |
OXA-48 |
| Imipenem plus cilastatin |
S |
32.6 |
OXA-1, OXA-2, OXA-10 |
31.1 |
OXA-1, OXA-2, OXA-10,OXA-23, |
| I |
4.1 |
OXA-10 |
9.5 |
OXA-10 |
| R |
63.3 |
OXA-23, OXA-24, OXA-48, OXA-51, OXA-58 |
59.5 |
OXA-10, OXA-23, OXA-24, OXA-48, OXA-51, OXA-58 |
Where S= susceptible, I=intermediate, R=resistant |
